Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

CGMs can be used for patients on insulin injections or insulin pump therapy for Type 1 or Type 2 diabetes. They are available either for personal use or for diagnostic use* by healthcare ...

There’s the continuous glucose monitoring (CGM) device, Dexcom, that reads my blood sugar, and with the new tandem system I ...

Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

1 mylife Loop consists of the mylife YpsoPump, a lightweight intuitive insulin pump, integrated with the CamAPS FX hybrid ...

Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging ...

The company’s diabetes segment lags behind competitors like DexCom and Abbott due to inferior CGM technology ... Recent recalls of insulin pumps may hinder growth in Medtronic's diabetes ...

And DexCom is building a network effect since its CGM systems are compatible with a host of other devices and third-party ...